GLAM
PTLA

Gardner Lewis Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Gardner Lewis Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-957,100
Closed -$17.2M – 84
2020
Q2 		$17.2M Buy
+957,100
New +$13.3M 3.18% 10

Gardner Lewis Asset Management's PTLA Position: Q3 2020 in Review

Gardner Lewis Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 957,100 shares — an estimated $17.2M sold.

Gardner Lewis Asset Management first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $17.2M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Gardner Lewis Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 957,100 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $17.2M.
  • Gardner Lewis Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Portola Pharmaceuticals, Inc. position peaked at $17.2M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Gardner Lewis Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.